Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Immuron.
RELATED STOCKHEAD STORIES
Experts
Scopo’s powerplays: It just won’t go down!
News
Weekly ASX small cap wrap: Who’s (literally) sinking the boat this week?
Health & Biotech
Check up: COVID-19 is back in fashion
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: What does a trillion dollars look like?
Health & Biotech
Imagion tech brings down Tesla
News
10 at 10: These ASX stocks are skating on this morning
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s getting an extension today?
Health & Biotech
Immuron’s diarrhoea drug may help treat COVID-19; investors get excited
Health & Biotech
Check up: Diarrhoea and the FDA are lifting share prices
News
Weekly ASX Small Cap Wrap: Who’s blundering around in the dark this week?
News
10 at 10: These ASX stocks are swinging swords this morning
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunchtime Wrap: Who thinks Warren Buffett is all washed up?
News
10 at 10: These ASX stocks are priming for a prize this morning
Health & Biotech